Michael Gelband’s CryoPort CYRX Stock Holding History

Michael Gelband’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$640K	Buy	+40,775	New	+$523K	﹤0.01%	1177
2024 Q4	–	Sell	-57,568	Closed	-$467K	–	1626
2024 Q3	$467K	Buy	+57,568	New	+$471K	﹤0.01%	1210
2024 Q1	–	Sell	-62,863	Closed	-$974K	–	1580
2023 Q4	$974K	Buy	62,863 +50,571	+411%	+$661K	0.01%	831
2023 Q3	$169K	Sell	12,292 -12,488	-50%	-$184K	﹤0.01%	1547
2023 Q2	$427K	Buy	+24,780	New	+$507K	﹤0.01%	1413
2022 Q4	–	Sell	-39,431	Closed	-$961K	–	1726
2022 Q3	$961K	Buy	+39,431	New	+$1.36M	0.01%	1124
2022 Q2	–	Sell	-7,743	Closed	-$270K	–	2029
2022 Q1	$270K	Buy	7,743 +4,352	+128%	+$165K	﹤0.01%	1801
2021 Q4	$201K	Buy	+3,391	New	+$235K	﹤0.01%	1826
2021 Q1	–	Sell	-6,391	Closed	-$280K	–	2192
2020 Q4	$280K	Buy	+6,391	New	+$304K	﹤0.01%	1577
2020 Q1	–	Sell	-10,110	Closed	-$166K	–	1178
2019 Q4	$166K	Buy	+10,110	New	+$150K	﹤0.01%	1373
2019 Q3	–	Sell	-11,100	Closed	-$203K	–	1388
2019 Q2	$203K	Buy	+11,100	New	+$176K	0.01%	920

Other funds holding CYRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Michael Gelband's CYRX Position: Q2 2026 in Review

Michael Gelband opened a new position in CryoPort (CYRX) in Q2 2026: 40,775 shares worth $640K. The stake represents ﹤0.01% of the portfolio and ranks #1177 among its holdings. This is a return to the name: Michael Gelband previously reported a position in CYRX as recently as Q3 2024.

Michael Gelband first reported a position in CYRX in Q2 2019 and has held it in 11 quarters since. The position peaked at $974K in Q4 2023. 184 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

Michael Gelband held 40,775 shares of CryoPort worth $640K as of Q2 2026.
CryoPort was a new Michael Gelband position in Q2 2026.
CryoPort made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1177 holding.
Michael Gelband first reported a position in CryoPort in Q2 2019 and has held it in 11 quarters since.
Michael Gelband's CryoPort position peaked at $974K in Q4 2023.
184 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.